I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 23 studies | 44% ± 26% | |
| astrocyte | 17 studies | 44% ± 23% | |
| microglial cell | 16 studies | 67% ± 21% | |
| oligodendrocyte | 15 studies | 54% ± 16% | |
| oligodendrocyte precursor cell | 14 studies | 53% ± 19% | |
| fibroblast | 13 studies | 35% ± 13% | |
| endothelial cell | 11 studies | 30% ± 15% | |
| myeloid cell | 8 studies | 45% ± 24% | |
| GABAergic neuron | 7 studies | 46% ± 17% | |
| endothelial cell of lymphatic vessel | 7 studies | 34% ± 13% | |
| adipocyte | 6 studies | 28% ± 8% | |
| dendritic cell | 6 studies | 37% ± 6% | |
| glutamatergic neuron | 5 studies | 43% ± 23% | |
| T cell | 5 studies | 26% ± 9% | |
| pericyte | 5 studies | 28% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 28% ± 6% | |
| CD8-positive, alpha-beta T cell | 3 studies | 23% ± 6% | |
| mononuclear phagocyte | 3 studies | 37% ± 10% | |
| regulatory T cell | 3 studies | 21% ± 6% | |
| connective tissue cell | 3 studies | 17% ± 1% | |
| B cell | 3 studies | 23% ± 9% | |
| monocyte | 3 studies | 46% ± 12% | |
| natural killer cell | 3 studies | 30% ± 5% | |
| lymphocyte | 3 studies | 30% ± 6% | |
| interneuron | 3 studies | 38% ± 12% |
